ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → 3-(3-Hydroxyazetidin-3-yl)-1,4-bis(phenylmethyl)piperazine-2,5-dione

HRID 1809033
印刷

反応式

HRID 1809033 の反応式
[O:1]=[C:2]1[N:7]([CH2:8][C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[CH2:6][C:5](=[O:15])[N:4]([CH2:16][C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=2)[CH:3]1[C:23]1([OH:34])[CH2:26][N:25](C(OC(C)(C)C)=O)[CH2:24]1.Cl.O1CCOCC1>CO>[OH:34][C:23]1([CH:3]2[N:4]([CH2:16][C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[C:5](=[O:15])[CH2:6][N:7]([CH2:8][C:9]3[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=3)[C:2]2=[O:1])[CH2:26][NH:25][CH2:24]1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 313Hydrochloric AcidHCID 312751,4-DioxaneHCID 67051729Tert-butyl 3-(1,4-dibenzyl-3,6-dioxopiperazin-2-yl)-3-hydroxyazetidine-1-carboxylate

生成物 1

HCID 670516393-(3-Hydroxyazetidin-3-yl)-1,4-bis(phenylmethyl)piperazine-2,5-dione収率 61%

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

実験手順

A solution of 1,1-dimethylethyl 3-[3,6-dioxo-1,4-bis(phenylmethyl)piperazin-2-yl]-3-hydroxyazetidine-1-carboxylate (1.04 g, 2.2 mmol) in methanol (10 mL) was treated with hydrogen chloride in dioxane (4 N, 5.5 mL, 22 mmol) at 60° C. for 25 min. After cooling to room temperature the solution was concentrated. Ethyl acetate and 2 N hydrochloric acid were added to the residue and the phases were separated. The organic phase was discarded. The aqueous phase was basified with 5 M sodium hydroxide and the resulting solution was extracted 4 times with ethyl acetate. The combined organic extracts were dried over magnesium sulfate, filtered, and concentrated. The residue was purified by column chromatography (85% dichloromethane: 14% methanol: 1% aqueous ammonium hydroxide) to provide 3-(3-hydroxyazetidin-3-yl)-1,4-bis(phenylmethyl)piperazine-2,5-dione as a colorless film (493 mg, 1.35 mmol, 61% yield). 1H NMR (400 MHz, CDCl3): 7.39-7.28 (m, 6H), 7.25-7.20 (m, 4H), 5.39 (d, 1H), 4.80 (d, 1H), 4.44 (d, 1H), 4.36 (d, 1H), 4.26 (d, 1H), 4.11 (s, 1H), 3.97 (d, 1H), 3.83 (d, 1H), 3.71 (d, 1H), 3.27 (m, 2H); MS (EI) for C21H23N3O3: 366 (MH+).

後処理

  1. concentrationwas concentrated
  2. additionEthyl acetate and 2 N hydrochloric acid were added to the residue
  3. customthe phases were separated
  4. extractionthe resulting solution was extracted 4 times with ethyl acetate
  5. dry with materialThe combined organic extracts were dried over magnesium sulfate
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe residue was purified by column chromatography (85% dichloromethane: 14% methanol: 1% aqueous ammonium hydroxide)

出典と根拠

ORDレコード
ord-5f358e66a8254657bcbbbb3a449a95cc
出典データセット
uspto-grants-2013_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08362002B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート